Hepatitis Inequalities Study

The Chinese University of Hong Kong

Status: Not yet enrolling

Conditions: Chronic Hepatitis B; HEPATITIS C VIRUS CHRONIC INFECTION

Study type: Observational

Funder types: Other

Identifiers

NCT06596213

CRE2024.361

Details and patient eligibility

About

Health inequality in liver diseases including age, gender, ethnicity and socioeconomic status has been increasingly recognised and potentially hinder hepatitis elimination. Health inequality has significant impact to evaluate the impact diagnostic and treatment uptake rates of chronic viral hepatitis on risk of hepatocellular carcinoma (HCC), hepatic event and liver-related death in patients with chronic hepatitis B and/or C. To overcome the limitation of small prospective cohort study of limited recruitment period, retrieving information from the Clinical Data Analysis and Reporting System (CDARS) from Hospital Authority (HA) will be one of the best way to answer these questions.

Enrollment: 100,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients will be eligible if they have any of these viral markers (HBeAg / HBsAg / HBV DNA / HCV RNA) and/or any of the following diagnosis codes (ICD-9 070-070.9; 348.3, 349.82, 456, 456.2, 456.8, 567.2, 567.8, 570, 571.2, 571.5, 571.6, 572.2, 572.3, 572.4, 789.5) checked or coded in any public hospitals or clinics from 1 January 2000 to 31 March 2024.

Exclusion criteria

• Patients with missing age, gender, ethnicity and socioeconomic status
• (Subgroup analysis for ethnicity and socioeconomic status) Patients with missing ethnicity and socioeconomic status
• Serious medical illnesses or malignancy with life expectancy <1 year